These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. beta-Blockers and myocardial infarction. Moser M; Gorlin R Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165 [No Abstract] [Full Text] [Related]
5. Alprenolol in acute myocardial infarction: Double-blind trial. Briant RB; Norris RM N Z Med J; 1970 Mar; 71(454):135-8. PubMed ID: 4392703 [No Abstract] [Full Text] [Related]
6. beta-Adrenergic blocking agents in the post-myocardial infarction patient. Goldstein S Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535 [No Abstract] [Full Text] [Related]
7. [Prevention of arrhythmia in myocardial infarct (secondary prevention)]. Gertsch M Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483 [No Abstract] [Full Text] [Related]
8. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
9. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers]. Lechat P Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729 [TBL] [Abstract][Full Text] [Related]
10. The role of long term beta-blockade after myocardial infarction: Paper 2. Rosenbaum M Aust Fam Physician; 1978 Jun; Suppl():34-7. PubMed ID: 30442 [TBL] [Abstract][Full Text] [Related]
11. Beta blockers and calcium channel blocking agents in acute myocardial infarction. Pearle DL; Rackley CE Cardiovasc Clin; 1986; 16(3):29-38. PubMed ID: 2875793 [No Abstract] [Full Text] [Related]
12. Use of beta-adrenergic blocking agents after myocardial infarction. Talbert RL Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362 [No Abstract] [Full Text] [Related]
13. [Beta-receptor blockers in acute myocardial infarction]. Hamm C Dtsch Med Wochenschr; 1990 Nov; 115(47):1811. PubMed ID: 1977572 [No Abstract] [Full Text] [Related]
14. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction]. Arós Borau F; Loma-Osorio A; Torres Bosco A Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518 [TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials. Friedewald WT Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641 [No Abstract] [Full Text] [Related]
16. Beta-blocker effectiveness post infarction: an antiarrhythmic or antiischemic effect. Hjalmarson A Ann N Y Acad Sci; 1984; 427():101-11. PubMed ID: 6146281 [No Abstract] [Full Text] [Related]
17. A review of long-term beta-blocker trials in survivors of myocardial infarction. May GS Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644 [No Abstract] [Full Text] [Related]
18. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction. Rotmensch HH; Vlasses PH; Ferguson RK Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686 [No Abstract] [Full Text] [Related]
19. [Ambulatory management of patients after myocardial infarction]. Bloch A Rev Med Suisse Romande; 2000 Feb; 120(2):159-66. PubMed ID: 10748703 [TBL] [Abstract][Full Text] [Related]
20. Medical prophylaxis for the post myocardial infarct patient. Cohen LS Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]